Targeting Viral Ion Channels: A Promising Strategy to Curb SARS-CoV-2
SARS-CoV-2 is the etiological agent COVID-19, one of the most impactful health crises afflicting humanity in recent decades. While research advances have yielded several treatment and prevention options, the pandemic is slow to abate, necessitating an expansion of our treatment arsenal. As a member...
Main Authors: | Anamika Singh, Isaiah T. Arkin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/4/396 |
Similar Items
-
Searching for Blockers of Dengue and West Nile Virus Viroporins
by: Hiya Lahiri, et al.
Published: (2022-08-01) -
Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing
by: Prabhat Pratap Singh Tomar, et al.
Published: (2021-03-01) -
Identification of SARS-CoV-2 E Channel Blockers from a Repurposed Drug Library
by: Prabhat Pratap Singh Tomar, et al.
Published: (2021-06-01) -
Inhibition of Radiation and Temozolomide-Induced Glioblastoma Invadopodia Activity Using Ion Channel Drugs
by: Marija Dinevska, et al.
Published: (2020-10-01) -
Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro
by: Yuyong Zhou, et al.
Published: (2021-10-01)